Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients

Citation
P. Fanti et al., Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients, J AM S NEPH, 10(4), 1999, pp. 864-871
Citations number
45
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
ISSN journal
10466673 → ACNP
Volume
10
Issue
4
Year of publication
1999
Pages
864 - 871
Database
ISI
SICI code
1046-6673(199904)10:4<864:SLAMCO>2.0.ZU;2-0
Abstract
Genistein and daidzein are biologically active isoflavones that are especia lly abundant in soybeans. After intestinal absorption, circulating genistei n and daidzein are eliminated primarily by the kidneys. This study was unde rtaken to assess the metabolism of genistein and daidzein in patients with end-stage renal disease (ESRD) on hemodialysis therapy, and to test whether this treatment modality can replace the lack of kidney function, with resp ect to the elimination of the isoflavones. Twenty-three hemodialysis patien ts and 10 healthy subjects were studied. While consuming a self-selected lo w isoflavone diet, baseline blood levels were undetectable in eight of 10 h ealthy subjects and in 14 of 23 dialysis patients. The remaining participan ts had detectable levels, with the nine dialysis patients displaying much h igher blood concentrations than the two healthy control subjects. After the evening intake of one dose of an isoflavone-rich soy protein isolate drink , the early morning blood levels of genistein and daidzein were higher in s even dialysis patients than in eight healthy subjects (genistein 1271 +/- 3 21 versus 425 +/- 104, P < 0.05; daidzein 1304 +/- 352 versus 292 +/- 78, P < 0.05). The brood clearance of the isoflavones was studied in two healthy subjects and in three dialysis patients. Genistein and daidzein were elimi nated within 2 d in the healthy subjects, but had not returned to baseline in two of three ESRD patients, 7 d after intake. The half-life of both comp ounds was estimated to be 10-fold longer in the ESRD patients than in the h ealthy subjects. Finally, genistein and daidzein levels were measured befor e and after dialysis in five patients, both while on their regular diet and after one dose of a soy protein isolate drink. In both instances, the dial ysis treatment did not affect the blood isoflavone levels. In conclusion, a pproximately one-third of hemodialysis patients eating the standard America n renal diet experience high blood levels of the isoflavones genistein and daidzein, while the remaining two-thirds have undetectable levels. After in gestion of isoflavone-rich food such as soy products, all patients have det ectable levels that remain very high for several days due to lack of renal excretion.